Literature DB >> 19996113

Molecular basis of myelodysplastic/myeloproliferative neoplasms.

Andreas Reiter, Rosangela Invernizzi, Nicholas C P Cross, Mario Cazzola.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19996113      PMCID： PMC2791938          DOI： 10.3324/haematol.2009.014001

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  22 in total

1.  Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosis.

Authors:  Johanna Flach; Frank Dicker; Susanne Schnittger; Alexander Kohlmann; Torsten Haferlach; Claudia Haferlach
Journal:  Haematologica       Date:  2009-11-10       Impact factor: 9.941

2.  Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia.

Authors:  Mario Cazzola; Rosangela Invernizzi; Gaetano Bergamaschi; Sonia Levi; Barbara Corsi; Erica Travaglino; Valeria Rolandi; Giorgio Biasiotto; Jim Drysdale; Paolo Arosio
Journal:  Blood       Date:  2002-10-24       Impact factor: 22.113

3.  250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies.

Authors:  Andrew J Dunbar; Lukasz P Gondek; Christine L O'Keefe; Hideki Makishima; Manjot S Rataul; Hadrian Szpurka; Mikkael A Sekeres; Xiao Fei Wang; Michael A McDevitt; Jaroslaw P Maciejewski
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

4.  Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates.

Authors:  A Tefferi; R L Levine; K-H Lim; O Abdel-Wahab; T L Lasho; J Patel; C M Finke; A Mullally; C-Y Li; A Pardanani; D G Gilliland
Journal:  Leukemia       Date:  2009-03-05       Impact factor: 11.528

5.  Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1.

Authors:  Mamta Tahiliani; Kian Peng Koh; Yinghua Shen; William A Pastor; Hozefa Bandukwala; Yevgeny Brudno; Suneet Agarwal; Lakshminarayan M Iyer; David R Liu; L Aravind; Anjana Rao
Journal:  Science       Date:  2009-04-16       Impact factor: 47.728

Review 6.  The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features.

Authors:  A Orazi; U Germing
Journal:  Leukemia       Date:  2008-05-15       Impact factor: 11.528

7.  P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?

Authors:  J V Melo; H Myint; D A Galton; J M Goldman
Journal:  Leukemia       Date:  1994-01       Impact factor: 11.528

8.  Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.

Authors:  Andrea Pellagatti; Mario Cazzola; Aristoteles A N Giagounidis; Luca Malcovati; Matteo G Della Porta; Sally Killick; Lisa J Campbell; Li Wang; Cordelia F Langford; Carrie Fidler; David Oscier; Carlo Aul; James S Wainscoat; Jacqueline Boultwood
Journal:  Blood       Date:  2006-03-09       Impact factor: 22.113

9.  Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes.

Authors:  Véronique Gelsi-Boyer; Virginie Trouplin; José Adélaïde; Nicola Aceto; Virginie Remy; Stephane Pinson; Claude Houdayer; Christine Arnoulet; Danielle Sainty; Mohamed Bentires-Alj; Sylviane Olschwang; Norbert Vey; Marie-Joëlle Mozziconacci; Daniel Birnbaum; Max Chaffanet
Journal:  BMC Cancer       Date:  2008-10-16       Impact factor: 4.430

10.  The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts.

Authors:  Jacqueline Boultwood; Andrea Pellagatti; Maryam Nikpour; Beena Pushkaran; Carrie Fidler; Helen Cattan; Tim J Littlewood; Luca Malcovati; Matteo G Della Porta; Martin Jädersten; Sally Killick; Aristoteles Giagounidis; David Bowen; Eva Hellström-Lindberg; Mario Cazzola; James S Wainscoat
Journal:  PLoS One       Date:  2008-04-09       Impact factor: 3.240
View more
  14 in total

1.  TET2 gene is not deleted in chronic myelomonocytic leukemia: a FISH retrospective study.

Authors:  Mar Mallo; Gemma Osca; Julia Solórzano; Leonor Arenillas; Lourdes Florensa; Francesc Solé
Journal:  Haematologica       Date:  2010-06-30       Impact factor: 9.941

2.  Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.

Authors:  Mario Cazzola
Journal:  Haematologica       Date:  2011-03       Impact factor: 9.941

3.  Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia.

Authors:  Manja Meggendorfer; Torsten Haferlach; Tamara Alpermann; Sabine Jeromin; Claudia Haferlach; Wolfgang Kern; Susanne Schnittger
Journal:  Haematologica       Date:  2014-09-19       Impact factor: 9.941

4.  The mutational landscape of 18 investigated genes clearly separates four subtypes of myelodysplastic/myeloproliferative neoplasms.

Authors:  Manja Meggendorfer; Sabine Jeromin; Claudia Haferlach; Wolfgang Kern; Torsten Haferlach
Journal:  Haematologica       Date:  2018-05       Impact factor: 9.941

5.  Cytogenetic risk stratification in chronic myelomonocytic leukemia.

Authors:  Esperanza Such; José Cervera; Dolors Costa; Francesc Solé; Teresa Vallespí; Elisa Luño; Rosa Collado; María J Calasanz; Jesús M Hernández-Rivas; Juan C Cigudosa; Benet Nomdedeu; Mar Mallo; Felix Carbonell; Javier Bueno; María T Ardanaz; Fernando Ramos; Mar Tormo; Reyes Sancho-Tello; Consuelo del Cañizo; Valle Gómez; Victor Marco; Blanca Xicoy; Santiago Bonanad; Carmen Pedro; Teresa Bernal; Guillermo F Sanz
Journal:  Haematologica       Date:  2010-11-25       Impact factor: 9.941

Review 6.  Clinical overview of cutaneous features in hypereosinophilic syndrome.

Authors:  Sabine Gisela Plötz; Bettina Hüttig; Birgit Aigner; Christian Merkel; Knut Brockow; Cezmi Akdis; Ulf Darsow; Johannes Ring
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

7.  Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.

Authors:  Rocco Piazza; Simona Valletta; Nils Winkelmann; Sara Redaelli; Roberta Spinelli; Alessandra Pirola; Laura Antolini; Luca Mologni; Carla Donadoni; Elli Papaemmanuil; Susanne Schnittger; Dong-Wook Kim; Jacqueline Boultwood; Fabio Rossi; Giuseppe Gaipa; Greta P De Martini; Paola Francia di Celle; Hyun Gyung Jang; Valeria Fantin; Graham R Bignell; Vera Magistroni; Torsten Haferlach; Enrico Maria Pogliani; Peter J Campbell; Andrew J Chase; William J Tapper; Nicholas C P Cross; Carlo Gambacorti-Passerini
Journal:  Nat Genet       Date:  2012-12-09       Impact factor: 38.330

8.  Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts.

Authors:  Véronique Gelsi-Boyer; Nathalie Cervera; François Bertucci; Mandy Brecqueville; Pascal Finetti; Anne Murati; Christine Arnoulet; Marie-Joelle Mozziconacci; Ken I Mills; Nicholas C P Cross; Norbert Vey; Daniel Birnbaum
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

Review 9.  Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable.

Authors:  Katerina Zoi; Nicholas C P Cross
Journal:  Int J Hematol       Date:  2014-09-12       Impact factor: 2.490

10.  Successful transplantation of ethnically mismatched cord blood in a boy with atypical chronic myeloid leukemia.

Authors:  Tang-Her Jaing; Iou-Jih Hung; Shih-Hsiang Chen; Wen-I Lee; Yu-Chuan Wen; En-Chen Fang
Journal:  Int J Hematol       Date:  2012-12-22       Impact factor: 2.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.